Table 1.
Clinicopathologic characteristics for bladder cancer patients
| Characteristics | N = 159 (%) |
|---|---|
| Age (yr) at diagnosis, mean ± SD | 66.8 ± 0.89 |
| Gender | |
| Male | 127 (79.9) |
| Female | 32 (20.1) |
| Pathologic T stage | |
| pTa | 54 (33.9) |
| pT1 | 64 (40.3) |
| ≥ pT2 | 41 (25.8) |
| Clinical N stage | |
| cN0 | 147 (92.5) |
| cN1-3 | 12 (7.5) |
| Clinical M stage | |
| cM0 | 153 (96.2) |
| cM1 | 6 (3.8) |
| Tumor gradea | |
| Low | 60 (37.7) |
| High | 99 (62.3) |
| Concomitant carcinoma in situ | |
| Absent | 123 (77.4) |
| Present | 36 (22.6) |
| Tumor size | |
| < 3 cm | 91 (57.2) |
| ≥ 3 cm | 68 (42.8) |
| Multiplicity | |
| Solitary | 53 (33.3) |
| Two | 26 (16.4) |
| ≥ Three | 80 (50.3) |
aWorld Health Organization (WHO) grading system (2016)